Archive

Year: 2026

All Year: 2026 Articles

Newest first · Page 1,141

Beyond Meat Collapses

Beyond Meat (NASDAQ: BYND) went public on May 2, 2019, at $25. It raised $241 million. Its stock soared 163% that day, and it briefly had a valuation of $3.77 billion. After announcing fourth-quarter…

Douglas A. McIntyre · 6 months ago

Goldman Sachs Is Very Bullish on 5 Dividend-Paying Energy Superstars

Goldman Sachs is the acknowledged leader in the investment landscape on Wall Street and worldwide. The firm’s top-notch research department continues to provide institutional and high-net-worth clients with the best ideas across the investment…

Lee Jackson · 6 months ago

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution has reshaped biopharma M&A strategy. With Novo Nordisk and Eli Lilly generating tens of billions in annual obesity drug revenue, large-cap acquirers are scouring the biotech landscape for the next transformative…

Trey Thoelcke · 6 months ago

5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up

Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and seek exposure to next-generation therapeutic platforms. Five biotechs stand out as compelling acquisition candidates, each offering a…

Trey Thoelcke · 6 months ago

What High-Income Earners Can Do to Pay Less in Taxes

A 36-year-old software engineer recently posted a screenshot of his annual income in the Salary subreddit. His gross pay is $333.6k per year, but he’s paying more than $75k in taxes each year. In…

Marc Guberti · 6 months ago